Molecular Predictors of Risk and Clinical Outcome in Patients with Bladder Cancer
Contact: Xifeng Wu, M.D., Ph.D.
| Number of Enrolled Cancer Patients/Survivors: | 2,401 |
|---|---|
| Years of Diagnoses of Enrolled Cancer Patients/Survivors: | 1997-present |
| Approximate Years of Follow-up: | 14 years (the longest) |
| Cancer Sites Represented: | Bladder |
| Biological Specimens Collected: |
Blood/Blood Fraction Urine |
| Treatment Outcome Measures: |
Physician/Medical Record Reported
|
| Co-morbidities at Study Entry: |
Diabetes Heart Disease Pulmonary Disease Other |
| Lifestyle Factors: |
Smoking Alcohol Use Diet Physical Activity Body Mass Index Weight Loss/Control Other |
| Treatment Data: |
Surgery Radiation Chemotherapy Hormonal Therapy Bone Marrow/Stem Cell Transplant |
| Treatment Data Assessed By: |
Electronic Record Chart Abstraction Patient Reported Questionnaire |
| Is the study open to collaboration? | Yes |